AORT | Andrew M. GreenSVP, Regulatory and Quality | Open market sell$287K | -22.2% | $24.97 | $287K | Sep 10, 2026 | Sep 11, 2026 |
AORT | Andrew M. GreenSVP, Regulatory and Quality | Open market sell$38.8K | -2.8% | $26.02 | $38.8K | Sep 3, 2026 | Sep 4, 2026 |
AORT | Andrew M. GreenSVP, Regulatory and Quality | Open market sell$177K | -10.9% | $27.27 | $177K | Sep 2, 2026 | Sep 4, 2026 |
AORT | James P. MackinPresident & CEO | Open market sell$2.03M | -7.4% | $28.96 | $2.03M | Aug 19, 2026 | Aug 20, 2026 |
AORT | Andrew M. GreenSVP, Regulatory and Quality | Open market sell$17.6K | -1.0% | $28.55 | $17.6K | Aug 14, 2026 | Aug 17, 2026 |
AORT | Lance A. BerryEVP, COO, CFO & Treasurer | Open market sell$20.4K | -0.3% | $28.55 | $20.4K | Aug 14, 2026 | Aug 17, 2026 |
AORT | Jean F. HollowaySVP, General Counsel | Open market sell$27.8K | -0.5% | $28.49 | $27.8K | Aug 12, 2026 | Aug 12, 2026 |
AORT | Jean F. HollowaySVP, General Counsel | Open market sell$341K | -4.6% | $38.00 | $341K | Mar 4, 2026 | Mar 4, 2026 |
AORT | Amy HortonVP, Chief Accounting Officer | Open market sell$34K | -0.6% | $37.78 | $34K | Mar 3, 2026 | Mar 4, 2026 |
AORT | Jean F. HollowaySVP, General Counsel | Open market sell$145K | -1.9% | $37.78 | $145K | Mar 3, 2026 | Mar 4, 2026 |
AORT | Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$81.2K | -3.5% | $37.78 | $81.2K | Mar 3, 2026 | Mar 4, 2026 |
AORT | John E. DavisChief Commercial Officer | Open market sell$173K | -1.9% | $37.78 | $173K | Mar 3, 2026 | Mar 4, 2026 |
AORT | Lance A. BerryEVP, COO, CFO & Treasurer | Open market sell$239K | -2.9% | $37.78 | $239K | Mar 3, 2026 | Mar 4, 2026 |
AORT | James P. MackinPresident & CEO | Open market sell$676K | -1.9% | $37.78 | $676K | Mar 3, 2026 | Mar 4, 2026 |
AORT | Amy HortonVP, Chief Accounting Officer | Open market sell$24.4K | -0.5% | $38.02 | $24.4K | Mar 2, 2026 | Mar 3, 2026 |
AORT | Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$57.5K | -3.6% | $38.02 | $57.5K | Mar 2, 2026 | Mar 3, 2026 |
AORT | James P. MackinPresident & CEO | Open market sell$567K | -1.7% | $38.02 | $567K | Mar 2, 2026 | Mar 3, 2026 |
AORT | Jean F. HollowaySVP, General Counsel | Open market sell$83K | -1.3% | $38.02 | $83K | Mar 2, 2026 | Mar 3, 2026 |
AORT | Lance A. BerryEVP, COO, CFO & Treasurer | Open market sell$197K | -2.9% | $38.02 | $197K | Mar 2, 2026 | Mar 3, 2026 |
AORT | John E. DavisChief Commercial Officer | Open market sell$106K | -1.3% | $38.02 | $106K | Mar 2, 2026 | Mar 3, 2026 |
AORT | Amy HortonVP, Chief Accounting Officer | Open market sell$29.6K | -0.7% | $35.69 | $29.6K | Feb 24, 2026 | Feb 25, 2026 |
AORT | Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$44.9K | -2.9% | $35.69 | $44.9K | Feb 24, 2026 | Feb 25, 2026 |
AORT | Jean F. HollowaySVP, General Counsel | Open market sell$59.5K | -1.1% | $35.69 | $59.5K | Feb 24, 2026 | Feb 25, 2026 |
AORT | James P. MackinPresident & CEO | Open market sell$497K | -1.8% | $35.69 | $497K | Feb 24, 2026 | Feb 25, 2026 |
AORT | Lance A. BerryEVP, COO, CFO & Treasurer | Open market sell$160K | -3.0% | $35.69 | $160K | Feb 24, 2026 | Feb 25, 2026 |
AORT | John E. DavisChief Commercial Officer | Open market sell$74.1K | -1.1% | $35.69 | $74.1K | Feb 24, 2026 | Feb 25, 2026 |
AORT | Amy HortonVP, Chief Accounting Officer | Open market sell$65.1K | -1.3% | $37.59 | $65.1K | Feb 23, 2026 | Feb 25, 2026 |
AORT | Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$91.1K | -5.3% | $37.59 | $91.1K | Feb 23, 2026 | Feb 25, 2026 |
AORT | Jean F. HollowaySVP, General Counsel | Open market sell$116K | -2.0% | $37.59 | $116K | Feb 23, 2026 | Feb 25, 2026 |
AORT | James P. MackinPresident & CEO | Open market sell$788K | -2.6% | $37.59 | $788K | Feb 23, 2026 | Feb 25, 2026 |
AORT | Lance A. BerryEVP, COO, CFO & Treasurer | Open market sell$187K | -3.3% | $37.59 | $187K | Feb 23, 2026 | Feb 25, 2026 |
AORT | John E. DavisChief Commercial Officer | Open market sell$142K | -1.9% | $37.59 | $142K | Feb 23, 2026 | Feb 25, 2026 |
AORT | John E. DavisChief Commercial Officer | Open market sell$226K | -2.5% | $45.11 | $226K | Dec 15, 2025 | Dec 17, 2025 |
AORT | Amy HortonVP, Chief Accounting Officer | Open market sell$203K | -3.4% | $44.42 | $203K | Dec 8, 2025 | Dec 9, 2025 |
AORT | Jean F. HollowaySVP, General Counsel | Open market sell$239K | -3.3% | $45.30 | $239K | Dec 3, 2025 | Dec 4, 2025 |
AORT | Jean F. HollowaySVP, General Counsel | Open market sell$92.8K | -1.3% | $45.30 | $92.8K | Dec 3, 2025 | Dec 4, 2025 |
AORT | Elizabeth A. HoffDirector | Open market sell$189K | -13.4% | $45.10 | $189K | Nov 18, 2025 | Nov 19, 2025 |
AORT | Amy HortonVP, Chief Accounting Officer | Open market sell$274K | -4.2% | $45.73 | $274K | Nov 17, 2025 | Nov 18, 2025 |
AORT | Amy HortonVP, Chief Accounting Officer | Open market sell$160K | -2.4% | $45.86 | $160K | Nov 13, 2025 | Nov 14, 2025 |
AORT | John E. DavisChief Commercial Officer | Open market sell$301K | -3.2% | $45.86 | $301K | Nov 13, 2025 | Nov 14, 2025 |
AORT | James P. MackinPresident & CEO | Open market sell$1.57M | -4.1% | $45.86 | $1.57M | Nov 13, 2025 | Nov 14, 2025 |
AORT | Jean F. HollowaySVP, General Counsel | Open market sell$264K | -3.4% | $45.86 | $264K | Nov 13, 2025 | Nov 14, 2025 |
AORT | Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$229K | -8.1% | $45.86 | $229K | Nov 13, 2025 | Nov 14, 2025 |
AORT | Jean F. HollowaySVP, General Counsel | Open market sell$132K | -1.7% | $44.62 | $132K | Nov 10, 2025 | Nov 12, 2025 |
AORT | James P. MackinPresident & CEO | Open market sell$784K | -2.1% | $44.62 | $784K | Nov 10, 2025 | Nov 12, 2025 |
AORT | John E. DavisChief Commercial Officer | Open market sell$151K | -1.6% | $44.62 | $151K | Nov 10, 2025 | Nov 12, 2025 |
AORT | Amy HortonVP, Chief Accounting Officer | Open market sell$79.8K | -1.2% | $44.62 | $79.8K | Nov 10, 2025 | Nov 12, 2025 |
AORT | Marshall S. StantonSVP, Clinical & MD Affair | Open market sell$114K | -4.0% | $44.62 | $114K | Nov 10, 2025 | Nov 12, 2025 |